Cel-Sci Corporation

Patent Applications and Registrations

Patent applications and USPTO patent grants for Cel-Sci Corporation.The latest application filed is for "novel peptides for vaccination and treatment of 2019-ncov infections".

Company Profile

5.13.15

Cel-Sci Corporation - Vienna VA US
Cel-Sci, Corp - Vienna VA
Cel-Sci Corp. - Vienna VA
Cel-Sci Corp. -
CEL-SCI Corporation - 8229 Boone Boulevard, Suite 802 Vienna VA
Cel Sci Corporation - Alexandria VA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Trademarks

Patent Activity

Patent	Date
NOVEL PEPTIDES FOR VACCINATION AND TREATMENT OF 2019-nCoV INFECTIONS App 20210268101 - Zimmerman; Daniel H.	2021-09-02
Methods of preparation and composition of peptide constructs useful for treatment of rheumatoid arthritis Grant 11,041,013 - Zimmerman June 22, 2	2021-06-22
Method for inducing an immune response against avian, swine, spanish, H1N1, H5N9 influenza viruses and formulations thereof Grant 10,238,747 - Zimmerman	2019-03-26
Method for inducing an immune response for treatment of cancer and autoimmune diseases or conditions Grant 10,179,164 - Zimmerman , et al. Ja	2019-01-15
Method for inducing an immune response and formulations thereof Grant 10,179,174 - Zimmerman , et al. Ja	2019-01-15
Methods Of Preparation And Composition Of Peptide Constructs Useful For Treatment Of Rheumatoid Arthritis App 20160158330 - Zimmerman; Daniel H. ; et al.	2016-06-09
Method For Inducing An Immune Response And Formulations Thereof App 20150140065 - Zimmerman; Daniel H. ; et al.	2015-05-21
Method For Inducing An Immune Response For Treatment Of Cancer And Autoimmune Diseases Or Conditions App 20140286858 - Zimmerman; Daniel H. ; et al.	2014-09-25
Method For Inducing An Immune Response Against Avian, Swine, Spanish, H1n1, H5n9 Influenza Viruses And Formulations Thereof App 20130266599 - Zimmerman; Daniel H.	2013-10-10
Compositions and Methods for Modulating Immunogenic Responses by Activating Dendritic Cells App 20120039926 - Rosenthal; Kenneth S. ; et al.	2012-02-16
Methods Of Preparation And Composition Of Peptide Constructs Useful For Treatment Of Rheumatoid Arthritis App 20110098444 - Zimmerman; Daniel H.	2011-04-28
Method for altering the CD4/CD8 ratio and the mononuclear cellular infiltrate into a tumor App 20080131396 - Talor; Eyal I.	2008-06-05
Method for Managing Cholesterol with a Serum-Free and Mitogen-Free Cytokine Mixture App 20080063625 - Kersten; Geert ; et al.	2008-03-13
Methods of preparation and composition of peptide constructs useful for treatment of autoimmune and transplant related host versus graft conditions Grant 7,256,254 - Zimmerman August 14, 2	2007-08-14
Peptide constructs for treating autoimmune and related diseases Grant 7,199,216 - Talor April 3, 2	2007-04-03
Methods of preparation and composition of peptide constructs useful for treatment of autoimmune and transplant related host versus graft conditions App 20060257420 - Zimmerman; Daniel H.	2006-11-16
Method for modulating HLA class II tumor cell surface expression with a cytokine mixture App 20060257357 - Talor; Eyal I.	2006-11-16
Preparation and composition of peptides useful for treatment of autoimmune and transplant related graft versus host conditions Grant 6,995,237 - Zimmerman February 7, 2	2006-02-07
T cell binding ligand peptides and method of inducing a cellular immune response Grant 6,951,647 - Zimmerman October 4, 2	2005-10-04
Method of pre-sensitizing cancer prior to treatment with radiation and/or chemotherapy and a novel cytokine mixture Grant 6,896,879 - Talor May 24, 2	2005-05-24
Immunogenic conjugated polypeptide for treatment of herpes simplex virus Grant 6,572,860 - Zimmerman , et al. June 3, 2	2003-06-03
Modified HGP-30 heteroconjugates, compositions and methods of use Grant 6,287,565 - Zimmerman , et al. September 11, 2	2001-09-11
Heterofunctional cellular immunological reagents, vaccines containing same and methods for the use of same Grant 6,096,315 - Zimmerman , et al. August 1, 2	2000-08-01
Heterofunctional cellular immunological reagents, vaccines containing same and methods for the use of same Grant 5,652,342 - Zimmerman , et al. July 29, 1	1997-07-29

Company Registrations

NCAGE Code	45FD9	CEL-SCI CORPORATION
CAGE Code	45FD9	CEL-SCI CORPORATION
S.A.M. Registration	45FD9 [102560141]	CEL-SCI CORPORATION
SEC	0000725363	CEL SCI CORP of COLORADO

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.